Found: 14
Select item for more details and to access through your institution.
In acute myeloid leukemia, B7-H1 (PD-L1) protection of blasts from cytotoxic T cells is induced by TLR ligands and interferon-gamma and can be reversed using MEK inhibitors.
- Published in:
- Cancer Immunology, Immunotherapy, 2010, v. 59, n. 12, p. 1839, doi. 10.1007/s00262-010-0909-y
- By:
- Publication type:
- Article
Genetic variations and haplotypes in TIM- 3 gene and the risk of gastric cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2010, v. 59, n. 12, p. 1851, doi. 10.1007/s00262-010-0910-5
- By:
- Publication type:
- Article
Evaluation of the immunogenicity of a single chain chimeric peptide composed of hCGβ and oLHα for inhibition of the growth of hCGβ-expressing cancer cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2010, v. 59, n. 12, p. 1771, doi. 10.1007/s00262-010-0902-5
- By:
- Publication type:
- Article
Alternative Ii-independent antigen-processing pathway in leukemic blasts involves TAP-dependent peptide loading of HLA class II complexes.
- Published in:
- Cancer Immunology, Immunotherapy, 2010, v. 59, n. 12, p. 1825, doi. 10.1007/s00262-010-0908-z
- By:
- Publication type:
- Article
Toll-like receptor-7 agonist administered subcutaneously in a prolonged dosing schedule in heavily pretreated recurrent breast, ovarian, and cervix cancers.
- Published in:
- Cancer Immunology, Immunotherapy, 2010, v. 59, n. 12, p. 1877, doi. 10.1007/s00262-010-0914-1
- By:
- Publication type:
- Article
Analysis of a cholera toxin B subunit (CTB) and human mucin 1 (MUC1) conjugate protein in a MUC1-tolerant mouse model.
- Published in:
- Cancer Immunology, Immunotherapy, 2010, v. 59, n. 12, p. 1801, doi. 10.1007/s00262-010-0906-1
- By:
- Publication type:
- Article
Seventh annual meeting of the Italian Network for Tumor Biotherapy (NIBIT), Siena, 1-3 October 2009.
- Published in:
- 2010
- By:
- Publication type:
- Proceeding
A phase I trial of adoptive transfer of allogeneic natural killer cells in patients with advanced non-small cell lung cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2010, v. 59, n. 12, p. 1781, doi. 10.1007/s00262-010-0904-3
- By:
- Publication type:
- Article
A complement-dependent cytotoxicity-enhancing anti-CD20 antibody mediating potent antitumor activity in the humanized NOD/Shi- scid, IL-2Rγ mouse lymphoma model.
- Published in:
- Cancer Immunology, Immunotherapy, 2010, v. 59, n. 12, p. 1791, doi. 10.1007/s00262-010-0905-2
- By:
- Publication type:
- Article
Urinary neopterin does not reflect the local antitumor immune milieu in ovarian cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2010, v. 59, n. 12, p. 1813, doi. 10.1007/s00262-010-0907-0
- By:
- Publication type:
- Article
Identification and characterization of a tumor infiltrating CD56/CD16 NK cell subset with specificity for pancreatic and prostate cancer cell lines.
- Published in:
- Cancer Immunology, Immunotherapy, 2010, v. 59, n. 12, p. 1757, doi. 10.1007/s00262-010-0897-y
- By:
- Publication type:
- Article
Immunization with a recombinant GnRH vaccine fused to heat shock protein 65 inhibits mammary tumor growth in vivo.
- Published in:
- Cancer Immunology, Immunotherapy, 2010, v. 59, n. 12, p. 1859, doi. 10.1007/s00262-010-0911-4
- By:
- Publication type:
- Article
Viral DNA contamination is responsible for Epstein-Barr virus detection in cytotoxic T lymphocytes stimulated in vitro with Epstein-Barr virus B-lymphoblastoid cell line.
- Published in:
- Cancer Immunology, Immunotherapy, 2010, v. 59, n. 12, p. 1867, doi. 10.1007/s00262-010-0913-2
- By:
- Publication type:
- Article
Inhibition of metastasis of syngeneic murine melanoma in vivo and vasculogenesis in vitro by monoclonal antibody C11C1 targeted to domain 5 of high molecular weight kininogen.
- Published in:
- Cancer Immunology, Immunotherapy, 2010, v. 59, n. 12, p. 1885, doi. 10.1007/s00262-010-0915-0
- By:
- Publication type:
- Article